Germ-Line Mutation Analysis in Patients with Multiple Endocrine Neoplasia Type 1 and Related Disorders
The American Journal of Human Genetics1998Vol. 63(2), pp. 455–467
Citations Over TimeTop 1% of 1998 papers
Sophie Giraud, Chang Zhang, Olga M. Serova-Sinilnikova, Virginie Wautot, Janine Salandre, Nathalie Buisson, Christine Waterlot, Catherine Bauters, Nicole Porchet, Jean‐Pierre Aubert, Philippe Émy, Guillaume Cadiot, Brigitte Delemer, Olivier Chabre, Patricia Niccoli, F Leprat, F Duron, Brigitte Emperauger, P Cougard, Pierre Goudet, E. Sarfati, Jean‐Paul Riou, Sylvie M. Guichard, Michel Rodier, A Meyrier, Philippe Caron, Marie‐Christine Vantyghem, M Assayag, Jean‐Louis Peix, Michel Pugeat, V. Rohmer, Michel B. Vallotton, Gilbert Lenoir, Patrick Gaudray, C Proye, B. Conte‐Devolx, Philippe Chanson, Yin Yao Shugart, David E. Goldgar, Arnaud Murat, Alain Calender
Related Papers
- → Differences between germline and somatic mutation rates in humans and mice(2017)431 cited
- → Multiple Endocrine Neoplasia Type 2(2017)1 cited
- → Multiple endocrine neoplasia type 2 and related genetic conditions(1995)2 cited
- → Pheochromocytoma in Multiple Endocrine Neoplasia Type 2(2021)
- → Multiple Endocrine Neoplasia Type 2(2020)